|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...7374757677787980818283...110111» |
- | Biomarker, Trial completion: Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=100, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed
- | Trial completion: Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | carboplatin / Generic mfg., docetaxel / Generic mfg., gemcitabine / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Beth Israel Deaconess Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Herceptin (trastuzumab) / Roche
Trial completion: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (clinicaltrials.gov) - Feb 19, 2014
P1, N=15, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Active, not recruiting --> Completed Suspended --> Completed
- | topotecan / Generic mfg., etoposide oral / Generic mfg.
Trial completion: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=24, Completed, Sponsor: Gynecologic Oncology Group
Suspended --> Completed Active, not recruiting --> Completed
- | topotecan / Generic mfg., cisplatin / Generic mfg.
Trial completion, Metastases: Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=400, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | topotecan / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=3, Completed, Sponsor: Fox Chase Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Biomarker, Trial completion: IRB 1996-0189: UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=180, Completed, Sponsor: University of Michigan Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=48, Completed, Sponsor: Gynecologic Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=40, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases: Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix (clinicaltrials.gov) - Feb 19, 2014
P1, N=29, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., gemcitabine / Generic mfg.
Trial completion: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=24, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., irinotecan / Generic mfg.
Trial completion: Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=35, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=384, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | topotecan / Generic mfg., mitoxantrone / Generic mfg., thiotepa / Generic mfg.
Trial completion, Metastases: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=50, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., cisplatin / Generic mfg.
Trial completion: Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix (clinicaltrials.gov) - Feb 19, 2014
P3, N=870, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Fenretinide in Treating Patients With Cervical Neoplasia (clinicaltrials.gov) - Feb 19, 2014
P3, N=39, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | melphalan / Generic mfg., thiotepa / Generic mfg.
Trial completion: Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission (clinicaltrials.gov) - Feb 19, 2014
P1, N=45, Completed, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | tamoxifen / Generic mfg.
Trial completion: S9630, Medroxyprogesterone in Treating Women With Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=313, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Metastases: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., vinorelbine tartrate / Generic mfg.
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=62, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases: Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=324, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed No longer recruiting --> Completed
- | cisplatin / Generic mfg., vincristine / Generic mfg.
Trial completion, Surgery: Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Gynecologic Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | isotretinoin / Generic mfg.
Trial completion: Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Hoag Memorial Hospital Presbyterian
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial completion, Metastases: Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | carboplatin / Generic mfg., cyclophosphamide / Generic mfg., mitoxantrone / Generic mfg.
Trial completion: Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Loyola University
Active, not recruiting --> Completed Recruiting --> Completed
- ||| Lynparza (olaparib) / Merck (MSD), AstraZeneca
Enrollment change, Metastases: Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=70, Active, not recruiting, Sponsor: AstraZeneca
Recruiting --> Completed N=57 --> 70
- | Enrollment change: Calcium for Prevention of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Feb 18, 2014
P3, N=200, Completed, Sponsor: Cairo University
N=57 --> 70 N=120 --> 200
- | Trial completion: Calcium for Prevention of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Feb 18, 2014
P3, N=200, Completed, Sponsor: Cairo University
N=120 --> 200 Recruiting --> Completed
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment open: Tivozanib As Maintenance Therapy In GYN (clinicaltrials.gov) - Feb 18, 2014
P2, N=60, Recruiting, Sponsor: Dana-Farber Cancer Institute
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Trial completion: European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System (clinicaltrials.gov) - Feb 18, 2014
P=N/A, N=1365, Completed, Sponsor: Becton, Dickinson and Company
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Enrollment change: Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=27, Completed, Sponsor: The Cleveland Clinic
Active, not recruiting --> Completed N=52 --> 27
- Trial completion: Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=27, Completed, Sponsor: The Cleveland Clinic
N=52 --> 27 Active, not recruiting --> Completed
- | Vigil (gemogenovatucel-T) / Gradalis
Enrollment open, Tumor cell: Salvage Ovarian FANG (clinicaltrials.gov) - Feb 17, 2014
P2, N=14, Recruiting, Sponsor: Gradalis, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- || somatropin / Generic mfg.
Enrollment closed: GeNeSIS: Observational Study of Somatropin Treatment in Children (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=23500, Active, not recruiting, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting
- ||| Zorbtive (somatropin) / EMD Serono
Biomarker, Trial completion: PREDICT LT FUP: Long Term Follow up Study of Predictive Markers in GHD and TS Children (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=182, Completed, Sponsor: Merck KGaA
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- desogestrel / Generic mfg.
Enrollment open, Surgery: Postoperative Desogestrel for Endometriosis Related Pain (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=40, Recruiting, Sponsor: Mahidol University
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- Preclinical, Trial termination: Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes (clinicaltrials.gov) - Feb 15, 2014
P2, N=102, Terminated, Sponsor: Northwestern University
Active, not recruiting --> Recruiting Recruiting --> Terminated; Low recruitment numbers
- Preclinical, Enrollment change: Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes (clinicaltrials.gov) - Feb 15, 2014
P2, N=102, Terminated, Sponsor: Northwestern University
Recruiting --> Terminated; Low recruitment numbers N=250 --> 102
- Trial completion: Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries (clinicaltrials.gov) - Feb 15, 2014
P=N/A, N=90, Completed, Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital
N=250 --> 102 Recruiting --> Completed
- Enrollment change: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin (clinicaltrials.gov) - Feb 13, 2014
P2, N=18, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed N=12 --> 18
- cisplatin / Generic mfg., everolimus / Generic mfg.
Enrollment change, Combination therapy, Metastases: Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer (clinicaltrials.gov) - Feb 12, 2014
P1, N=0, Withdrawn, Sponsor: Accelerated Community Oncology Research Network
N=12 --> 18 N=18 --> 0
- Enrollment change: FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer (clinicaltrials.gov) - Feb 12, 2014
P2, N=16, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
N=18 --> 0 N=40 --> 16
- veliparib (ABT-888) / AbbVie
Enrollment closed, Combination therapy, BRCA Biomarker, PARP Biomarker, Metastases: Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer (clinicaltrials.gov) - Feb 12, 2014
P1, N=56, Active, not recruiting, Sponsor: University of Washington
N=40 --> 16 Recruiting --> Active, not recruiting
- ||||||| Ixempra (ixabepilone) - Otsuka, R / Pharm, Allarity Therap
Trial completion, Metastases: IXAMPLE2: A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer (clinicaltrials.gov) - Feb 11, 2014
P3, N=500, Completed, Sponsor: Bristol-Myers Squibb
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || Enrollment change: Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study (clinicaltrials.gov) - Feb 10, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: Auxogyn, Inc.
Active, not recruiting --> Completed N=600 --> 300